The design, synthesis and biological evaluation of a novel series of oxazinyl isoflavonoids is described. Several analogs were shown to exhibit growth inhibitory effects against SKOV-3, DU-145 and HL-60 human colon cancer cell lines with IC(50) values in the micromolar range. The cellular potency of compounds 7e and 12h were found to have greater in vitro inhibitory activities than phenoxodiol, the parental compound currently in late-stage clinical trials for the treatment of cancer. The results shown are suitable for further lead optimization.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1248/cpb.60.513 | DOI Listing |
Publication Analysis
Top Keywords
oxazinyl isoflavonoids
8
synthesis anti-tumor
4
anti-tumor activities
4
activities novel
4
novel oxazinyl
4
isoflavonoids design
4
design synthesis
4
synthesis biological
4
biological evaluation
4
evaluation novel
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!